A brown liquid from a dropper bottle was analyzed via GC/MS and found to contain an active level of LSD along with inactive levels (relative to the LSD) of MDMA and Ketamine. The sample also contained the MDMA synthesis byproduct Methylenedioxypropanol, and an antioxidant.
We don't really know what's going on with this sample, but either this bottle was used to store MDMA, then later ketamine, and then finally to hold acid, all without washing the bottle out in between substances; or MDMA and ketamine were added to an LSD preparation at intentionally homeopathic levels -- but that seems less likely.
It's curious, either way.
Send in a sample for testing
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.
We don't really know what's going on with this sample, but either this bottle was used to store MDMA, then later ketamine, and then finally to hold acid, all without washing the bottle out in between substances; or MDMA and ketamine were added to an LSD preparation at intentionally homeopathic levels -- but that seems less likely.
It's curious, either way.